This all could be put to bed if the Patents were listed in Half Yearly and Annual Reports, or classed as an asset, along with the only patent they list in said reports - a respiratory patent.
Just saying
Paradigm patent rejection, page-18
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $187.1K | 755.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47906 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 13363 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |